Orlando, Florida (PRWEB) June 07, 2014
The American College of sports medicine celebrated it 60th year with its annual meeting May 27, 2014. The meeting highlighted the World Congress on the role of inflammation in exercise health and disease.
SevenPoint2 supported a clinical trial through its association with Researcher Sergej Ostojic, titled The Effectiveness of Molecular Hydrogen in the Management of Musculotendinous Injuries. The study was under the auspices of University of Central Florida College of Education and Human Performance. The study revealed that a single week molecular hydrogen intervention augmented plasma viscosity decrease and speeding up recovery from limb swelling in male athletes suffering from sports related injuries.
The primary finding in this study provided evidence that molecular hydrogen maybe effective as an additional agent to traditional treatments in male professional athletes.
SevenPoint2 Director of Corporate Development Bill Sickert was elated after the conference. The stature and credibility of the clinical presentations at the ACSM Annual Meeting was a fantastic opportunity for increasing the awareness of SevenPoint2 in the marketplace. Sevenpoint2 and the Molecular Hydrogen product Recovery with HydroFX® was received with excitement as people visited the SevenPoint2 booth for more specific information on the SevenPoint2 family of products.
SevenPoint2 introduces, educates, and shares knowledge and products about our most precious resource, health. With "Health Made Simple" we actively educate people on the value of a Alkaline Diet. SevenPoint2 leads the “Alkaline Movement” with the safest, most satisfying Alkaline Diet products available to the public today.
CEO & Co-Founder
17 Corporate Plaza Dr, #232
Newport Beach, CA 92660
Office Hours: 8:30-5:00 PST